US Bancorp’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $354K | Buy |
30,537
+24,564
| +411% | +$284K | ﹤0.01% | 1692 |
|
|
2025
Q1 | $52.1K | Buy |
5,973
+4,532
| +315% | +$39.6K | ﹤0.01% | 2715 |
|
|
2024
Q4 | $20.7K | Sell |
1,441
-5,452
| -79% | -$78.3K | ﹤0.01% | 3135 |
|
|
2024
Q3 | $156K | Sell |
6,893
-1,724
| -20% | -$38.9K | ﹤0.01% | 2169 |
|
|
2024
Q2 | $168K | Sell |
8,617
-5,275
| -38% | -$103K | ﹤0.01% | 2083 |
|
|
2024
Q1 | $521K | Sell |
13,892
-1,320
| -9% | -$49.5K | ﹤0.01% | 1479 |
|
|
2023
Q4 | $851K | Buy |
15,212
+2,469
| +19% | +$138K | ﹤0.01% | 1202 |
|
|
2023
Q3 | $526K | Sell |
12,743
-567
| -4% | -$23.4K | ﹤0.01% | 1350 |
|
|
2023
Q2 | $743K | Buy |
13,310
+7,701
| +137% | +$430K | ﹤0.01% | 1186 |
|
|
2023
Q1 | $313K | Buy |
5,609
+726
| +15% | +$40.5K | ﹤0.01% | 1658 |
|
|
2022
Q4 | $178K | Sell |
4,883
-8,289
| -63% | -$302K | ﹤0.01% | 1922 |
|
|
2022
Q3 | $375K | Sell |
13,172
-1,330
| -9% | -$37.9K | ﹤0.01% | 1534 |
|
|
2022
Q2 | $657K | Buy |
14,502
+4,791
| +49% | +$217K | ﹤0.01% | 1290 |
|
|
2022
Q1 | $739K | Buy |
9,711
+2,753
| +40% | +$210K | ﹤0.01% | 1326 |
|
|
2021
Q4 | $1.04M | Buy |
6,958
+1,318
| +23% | +$196K | ﹤0.01% | 1184 |
|
|
2021
Q3 | $821K | Buy |
5,640
+397
| +8% | +$57.8K | ﹤0.01% | 1283 |
|
|
2021
Q2 | $1.03M | Buy |
5,243
+652
| +14% | +$128K | ﹤0.01% | 1186 |
|
|
2021
Q1 | $831K | Buy |
4,591
+4,391
| +2,196% | +$795K | ﹤0.01% | 1238 |
|
|
2020
Q4 | $28K | Hold |
200
| – | – | ﹤0.01% | 2747 |
|
|
2020
Q3 | $25K | Hold |
200
| – | – | ﹤0.01% | 2678 |
|
|
2020
Q2 | $18K | Hold |
200
| – | – | ﹤0.01% | 2817 |
|
|
2020
Q1 | $12K | Hold |
200
| – | – | ﹤0.01% | 2910 |
|
|
2019
Q4 | $15K | Buy |
+200
| New | +$15K | ﹤0.01% | 2948 |
|